Cerebellin 3 inhibitors are a class of compounds that target and inhibit the activity of Cerebellin 3, a protein that is part of the cerebellin family, which includes synaptic organizers involved in the regulation and stabilization of neural connections. Cerebellin 3 plays a key role in the development and maintenance of excitatory synapses by acting as a bridge between presynaptic and postsynaptic elements, similar to other cerebellin proteins. It forms complexes with neurexins on the presynaptic side and interacts with postsynaptic receptors like GluD on the postsynaptic side. These interactions are critical for the proper alignment and functional integrity of synaptic connections, which are essential for efficient neural communication and the establishment of neural networks.
Inhibitors of Cerebellin 3 are used in research to study the molecular mechanisms governing synapse formation and stability. By blocking the activity of Cerebellin 3, these inhibitors disrupt the organization of synaptic components, providing insight into how changes in synaptic structure affect neural function. Research utilizing these inhibitors focuses on understanding how impaired synapse formation influences neural circuitry, synaptic plasticity, and the overall connectivity of the nervous system. These studies often involve detailed observations of how neural networks respond to reduced synaptic organization, allowing researchers to explore the broader impact of synapse disassembly or dysfunction on cognitive and behavioral processes. The inhibition of Cerebellin 3 thus offers a valuable tool for dissecting the precise roles that synaptic organizers play in the development and adaptation of neural circuits.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic Acid may activate transcriptional repressors that directly bind to the promoter region of Cerebellin 3, leading to its downregulation. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
The hormonally active form of Cholecalciferol, calcitriol, could repress Cerebellin 3 transcription by binding to vitamin D response elements adjacent to the gene. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Methotrexate could decrease the availability of methyl groups required for gene silencing, potentially reducing Cerebellin 3 expression via changes in DNA methylation patterns. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic Acid might directly suppress Cerebellin 3 by increasing histone acetylation levels, leading to the expression of genes that repress Cerebellin 3 transcription. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Bisphenol A may disrupt normal hormonal signaling pathways that control the transcription of Cerebellin 3, leading to decreased expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin could reduce transcription factor accessibility to the Cerebellin 3 promoter or enhance the expression of microRNAs that target Cerebellin 3 mRNA for degradation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride might disrupt Wnt/β-catenin signaling, potentially leading to the transcriptional repression of downstream target genes including Cerebellin 3. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium Butyrate may lead to the hyperacetylation of histones near the Cerebellin 3 gene, which could result in the recruitment of transcriptional co-repressors and subsequent downregulation. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $312.00 | 9 | |
Fluoxetine could decrease Cerebellin 3 expression by altering serotonergic signaling pathways that are upstream regulators of the gene's transcription. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $87.00 $224.00 | ||
Arsenic Trioxide may induce epigenetic changes that lead to the silencing of genes including Cerebellin 3, specifically through the induction of histone deacetylases. |